NASDAQ : HIND
Vyome Holdings, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.28M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Vyome Holdings, Inc. (HIND) reported revenue of 129.72K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 129.72K | 319.71K | 256.94K | 415.94K | 382.87K |
| Cost of Revenue | 61.30K | 100.94K | 61.97K | 146.62K | 236.75K |
| Gross Profit | 68.42K | 218.77K | 194.97K | 269.32K | 146.12K |
| Selling, General & Admin | 2.68M | 2.37M | 898.57K | 768.00K | 826.60K |
| Research & Development | 1.59M | 588.26K | 285.39K | 316.78K | 423.70K |
| Operating Expenses | 4.28M | 2.97M | 1.20M | 1.11M | 1.25M |
| Operating Income | -4.22M | -2.75M | -1.01M | -836.65K | -1.10M |
| Interest Expense | -41.72K | -146.64K | -206.00K | -175.71K | -124.98K |
| Other Non Operating Income (Expenses) | -7.61M | -7.58M | -235.12K | 212.50K | -26.13K |
| Pretax Income | -11.58M | -10.48M | -1.45M | -799.86K | -1.26M |
| Earnings From Continuing Operations | -11.58M | -10.48M | -1.45M | -799.86K | -1.26M |
| Minority Interest in Earnings | 272.44K | 215.71K | |||
| Net Income | -11.31M | -10.26M | -1.45M | -799.86K | -1.26M |
| Net Income to Common | -11.31M | -10.26M | -1.45M | -799.86K | -1.26M |
| Shares Outstanding (Basic) | 7.02M | 2.16M | |||
| Shares Outstanding (Diluted) | 7.02M | 2.16M | |||
| EPS (Basic) | -1.61 | -4.75 | |||
| EPS (Diluted) | -1.61 | -4.75 | |||
| Gross Margin | 52.74% | 68.43% | 75.88% | 64.75% | 38.16% |
| Operating Margin | -3,250.23% | -859.22% | -391.66% | -201.15% | -288.40% |
| Profit Margin | -8,716.70% | -3,209.75% | -563.34% | -192.30% | -327.87% |
| EBITDA | -4.21M | -2.74M | -988.99K | -815.46K | -1.05M |
| EBITDA Margin | -196.05% | -273.74% | |||
| D&A For EBITDA | 10.71K | 11.98K | 17.35K | 21.19K | 56.15K |
| EBIT | -4.22M | -2.75M | -1.01M | -836.65K | -1.10M |
| EBIT Margin | -201.15% | -288.40% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 7.89M | 4.98M | 101.90K | 16.65K | 458.24K |
| Cash & Short-Term Investments | 7.89M | 4.98M | 101.90K | 16.65K | 458.24K |
| Accounts Receivable | 2.18K | 325.00 | 2.29K | 66.82K | 122.00 |
| Other Receivables | 150.48K | 98.29K | 48.65K | ||
| Receivables | 152.66K | 98.61K | 50.94K | 66.82K | 122.00 |
| Prepaid Expenses | 94.46K | 336.69K | 9.04K | ||
| Other Current Assets | 18.71K | 20.69K | 140.16K | 86.37K | 72.84K |
| Total Current Assets | 8.15M | 5.44M | 302.05K | 169.83K | 531.21K |
| Property, Plant & Equipment | 57.21K | 75.82K | 118.57K | 163.90K | 143.23K |
| Other Intangible Assets | 314.19K | 314.19K | 314.19K | 314.19K | 314.19K |
| Long-Term Deferred Charges | 111.42K | 66.42K | |||
| Other Long-Term Assets | 651.61K | 668.84K | 646.76K | 697.83K | 734.37K |
| Total Assets | 9.18M | 6.50M | 1.38M | 1.46M | 1.79M |
| Accounts Payable | 546.70K | 647.53K | 501.92K | 589.84K | 586.31K |
| Accrued Expenses | 1.20M | 1.96M | 1.49M | 2.27M | 1.87M |
| Current Portion of Long-Term Debt | 3.59M | 1.96M | 583.51K | ||
| Current Portion of Leases | 17.31K | 31.26K | 28.02K | 25.04K | 42.66K |
| Other Current Liabilities | 101.53K | 93.10K | 131.50K | 1.75M | 1.82M |
| Total Current Liabilities | 1.86M | 2.74M | 5.74M | 6.60M | 4.91M |
| Long-Term Debt | 967.50K | 2.25M | |||
| Long-Term Leases | 32.83K | 62.02K | |||
| Total Liabilities | 1.86M | 2.74M | 5.77M | 7.63M | 7.15M |
| Common Stock | 7.02K | 5.92K | 1.89K | 1.89K | |
| Additional Paid-In Capital | 95.37M | 90.08M | 51.08M | 868.60K | 643.71K |
| Retained Earnings | -89.21M | -87.56M | -55.42M | -53.98M | -53.21M |
| Comprehensive Income & Other | -119.88K | -78.86K | -53.17K | -54.30K | 212.41K |
| Total Common Equity | 6.05M | 2.44M | -4.39M | -53.16M | -52.35M |
| Minority Interest | 1.26M | 1.32M | 1.00 | ||
| Shareholders' Equity | 7.31M | 3.76M | -4.39M | -6.17M | -5.37M |
| Total Liabilities & Equity | 9.18M | 6.50M | 1.38M | 1.46M | 1.79M |
| Total Debt | 17.31K | 31.26K | 3.65M | 3.02M | 2.87M |
| Net Cash (Debt) | 7.87M | 4.95M | -3.55M | -3.00M | -2.42M |
| Net Cash Per Share | 1.12 | 2.29 | |||
| Filing Date Shares Outstanding | 7.02M | 7.02M | |||
| Total Common Shares Outstanding | 7.02M | 5.92M | |||
| Working Capital | 6.29M | 2.70M | -5.44M | -6.43M | -4.37M |
| Book Value Per Share | 0.86 | 0.41 | |||
| Tangible Book Value | 5.73M | 2.13M | -4.71M | -53.47M | -52.66M |
| Tangible Book Value Per Share | 0.82 | 0.36 | |||
| Buildings | 116.55K | 122.61K | 128.78K | 132.45K | 160.46K |
| Machinery | 428.32K | 448.09K | 478.12K | 507.12K | 588.03K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -11.31M | -10.26M | -1.45M | -799.86K | -1.26M |
| Depreciation & Amortization | 10.71K | 11.98K | 17.35K | 21.19K | 56.15K |
| Stock-Based Compensation | 6.62M | 6.58M | 25.01K | ||
| Other Operating Activities | -250.26K | -115.56K | 425.59K | -51.32K | 271.36K |
| Change in Accounts Receivable | -3.81K | -66.69K | -76.00 | ||
| Change in Inventory | 22.61K | ||||
| Change in Accounts Payable | 8.31K | 171.34K | -58.86K | 87.22K | 104.21K |
| Change in Other Net Operating Assets | -659.52K | -131.44K | 449.25K | 243.06K | 413.16K |
| Operating Cash Flow | -5.58M | -3.75M | -614.14K | -566.40K | -362.88K |
| Sale of Property, Plant & Equipment | 315.00 | 486.00 | 68.00 | ||
| Investing Cash Flow | 315.00 | 486.00 | 68.00 | ||
| Short-Term Debt Issued | 791.25K | 697.95K | 27.65K | ||
| Long-Term Debt Issued | 150.00K | 725.00K | |||
| Total Debt Issued | 791.25K | 697.95K | 150.00K | 752.65K | |
| Short-Term Debt Repaid | -25.22K | ||||
| Total Debt Repaid | -25.22K | ||||
| Net Debt Issued (Repaid) | 791.25K | 697.95K | 124.78K | 752.65K | |
| Issuance of Common Stock | 13.15M | 7.86M | |||
| Financing Cash Flow | 13.15M | 8.65M | 697.95K | 124.78K | 752.65K |
| Foreign Exchange Rate Adjustments | -66.72K | -25.69K | 1.13K | -468.00 | 208.00 |
| Miscellaneous Cash Flow Adjustments | -1.00 | ||||
| Net Cash Flow | 7.50M | 4.88M | 85.26K | -441.60K | 390.05K |
| Levered Free Cash Flow | 3.64M | 5.11M | -3.28M | -357.95K | |
| Unlevered Free Cash Flow | 3.67M | 5.20M | -3.15M | -248.13K | |
| Change in Working Capital | -655.02K | 39.91K | 390.39K | 263.59K | 539.90K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 12.63M | 19.42M | |||
| Enterprise Value | 4.76M | 15.14M | |||
| Last Close Price | 1.80 | 3.44 | |||
| PS Ratio | 97.39 | 60.73 | |||
| PB Ratio | 2.09 | 5.16 | |||
| P/TBV Ratio | 2.20 | 9.12 | |||
| EV/Sales Ratio | 36.72 | 47.35 | |||
| Debt / Equity Ratio | 0.00 | 0.01 | -0.83 | -0.49 | -0.54 |
| Net Debt / Equity Ratio | -1.08 | -1.32 | -0.81 | -0.49 | -0.45 |
| Net Debt / EBITDA Ratio | 1.87 | 1.81 | -3.59 | -3.68 | -2.31 |
| Asset Turnover | 0.02 | 0.08 | 0.18 | 0.26 | |
| Quick Ratio | 4.31 | 1.86 | 0.03 | 0.01 | 0.09 |
| Current Ratio | 4.37 | 1.99 | 0.05 | 0.03 | 0.11 |
| Return on Assets (ROA) | -48.79% | -43.58% | -44.31% | -32.21% | |
| Return on Capital Employed (ROCE) | -57.70% | -73.00% | 23.10% | 16.30% | 35.40% |
| Earnings Yield | -89.51% | -52.85% |